Overview

Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)

Status:
Completed
Trial end date:
2021-06-16
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of ibrutinib in combination with prednisone in subjects with newly diagnosed moderate to severe cGVHD.
Phase:
Phase 3
Details
Lead Sponsor:
Pharmacyclics LLC.
Collaborator:
Janssen Research & Development, LLC
Treatments:
Prednisone